Rafii MS - Search Results

1

Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.

Rafii MS, Tuszynski MH, Thomas RG, Barba D, Brewer JB, Rissman RA, Siffert J, Aisen PS; AAV2-NGF Study Team. Rafii MS, et al. JAMA Neurol. 2018 Jul 1;75(7):834-841. doi: 10.1001/jamaneurol.2018.0233. JAMA Neurol. 2018. PMID: 29582053 Free PMC article. Clinical Trial.

2

Recent developments in Alzheimer's disease therapeutics.

Rafii MS, Aisen PS. Rafii MS, et al. BMC Med. 2009 Feb 19;7:7. doi: 10.1186/1741-7015-7-7. BMC Med. 2009. PMID: 19228370 Free PMC article. Review.

3

High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment.

Kovacevic S, Rafii MS, Brewer JB; Alzheimer's Disease Neuroimaging Initiative. Kovacevic S, et al. Among authors: rafii ms. Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):139-45. doi: 10.1097/WAD.0b013e318192e745. Alzheimer Dis Assoc Disord. 2009. PMID: 19474571 Free PMC article.

4

Functional brain imaging in the clinical assessment of consciousness.

Rafii MS, Brewer JB. Rafii MS, et al. PLoS Biol. 2010 Nov 30;8(11):e1000548. doi: 10.1371/journal.pbio.1000548. PLoS Biol. 2010. PMID: 21151340 Free PMC article.

5

An expanded role for neuroimaging in the evaluation of memory impairment.

Desikan RS, Rafii MS, Brewer JB, Hess CP. Desikan RS, et al. Among authors: rafii ms. AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2075-82. doi: 10.3174/ajnr.A3644. Epub 2013 Jun 13. AJNR Am J Neuroradiol. 2013. PMID: 23764728 Free PMC article.

6

Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer's disease.

Rafii MS, Taylor CS, Kim HT, Desikan RS, Fleisher AS, Katibian D, Brewer JB, Dale AM, Aisen PS. Rafii MS, et al. Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):159-65. doi: 10.1177/1533317513507373. Epub 2013 Oct 27. Am J Alzheimers Dis Other Demen. 2014. PMID: 24164929 Free PMC article.

7

A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.

Rafii MS, Baumann TL, Bakay RA, Ostrove JM, Siffert J, Fleisher AS, Herzog CD, Barba D, Pay M, Salmon DP, Chu Y, Kordower JH, Bishop K, Keator D, Potkin S, Bartus RT. Rafii MS, et al. Alzheimers Dement. 2014 Sep;10(5):571-81. doi: 10.1016/j.jalz.2013.09.004. Epub 2014 Jan 7. Alzheimers Dement. 2014. PMID: 24411134 Clinical Trial.

8

Advances in Alzheimer's disease drug development.

Rafii MS, Aisen PS. Rafii MS, et al. BMC Med. 2015 Mar 25;13:62. doi: 10.1186/s12916-015-0297-4. BMC Med. 2015. PMID: 25857341 Free PMC article. Review.

9

The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome.

Rafii MS, Wishnek H, Brewer JB, Donohue MC, Ness S, Mobley WC, Aisen PS, Rissman RA. Rafii MS, et al. Front Behav Neurosci. 2015 Sep 14;9:239. doi: 10.3389/fnbeh.2015.00239. eCollection 2015. Front Behav Neurosci. 2015. PMID: 26441570 Free PMC article.

10

Targeting tau protein in Alzheimer's disease.

Rafii MS. Rafii MS. Lancet. 2016 Dec 10;388(10062):2842-2844. doi: 10.1016/S0140-6736(16)32107-9. Epub 2016 Nov 16. Lancet. 2016. PMID: 27863808 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters